APO RESEARCH · REPORT
Intravenous Solutions (Colloids)
There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.
Product & engineering
Understand the product.
There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.
Selected research
Industry Research
Intravenous Solutions (Colloids) Industry Research Report 2026
Market perspective
There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.
Global Intravenous Solutions (Colloids) key players include ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, etc.
Report Scope
Read the full market overview
This report quantifies the global Intravenous Solutions (Colloids) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Intravenous Solutions (Colloids) Market by Company
ICU Medical Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols S.A.
Intravenous Solutions (Colloids) Segment by Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition
Intravenous Solutions (Colloids) Segment by Application
Hospital and Clinics
Ambulatory
Home Care
Intravenous Solutions (Colloids) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Solutions (Colloids) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Intravenous Solutions (Colloids) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Solutions (Colloids).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Intravenous Solutions (Colloids) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Intravenous Solutions (Colloids) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Intravenous Solutions (Colloids) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Peripheral Parenteral Nutrition
- Total Parenteral Nutrition
Applications
- Hospital and Clinics
- Ambulatory
- Home Care
Companies covered
- ICU Medical Inc.
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Baxter
- Amanta Healthcare
- Terumo Medical Corporation
- Grifols S.A.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Intravenous Solutions (Colloids) Market Size (2021-2032)
- 2.2.2 Global Intravenous Solutions (Colloids) Sales (2021-2032)
- 2.2.3 Global Intravenous Solutions (Colloids) Market Average Price (2021-2032)
- 2.3 Intravenous Solutions (Colloids) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Peripheral Parenteral Nutrition
- 2.3.3 Total Parenteral Nutrition
- 2.4 Intravenous Solutions (Colloids) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital and Clinics
- 2.4.3 Ambulatory
- 2.4.4 Home Care
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Intravenous Solutions (Colloids) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Intravenous Solutions (Colloids) Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Intravenous Solutions (Colloids) Revenue of Manufacturers (2021-2026)
- 3.4 Global Intravenous Solutions (Colloids) Average Price by Manufacturers (2021-2026)
- 3.5 Global Intravenous Solutions (Colloids) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Intravenous Solutions (Colloids), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Intravenous Solutions (Colloids), Product Type & Application
- 3.8 Global Manufacturers of Intravenous Solutions (Colloids), Established Date
- 3.9 Global Intravenous Solutions (Colloids) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ICU Medical Inc.
- 4.1.1 ICU Medical Inc. Company Information
- 4.1.2 ICU Medical Inc. Business Overview
- 4.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 ICU Medical Inc. Intravenous Solutions (Colloids) Product Portfolio
- 4.1.5 ICU Medical Inc. Recent Developments
- 4.2 B. Braun Melsungen AG
- 4.2.1 B. Braun Melsungen AG Company Information
- 4.2.2 B. Braun Melsungen AG Business Overview
- 4.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Portfolio
- 4.2.5 B. Braun Melsungen AG Recent Developments
- 4.3 Fresenius Kabi AG
- 4.3.1 Fresenius Kabi AG Company Information
- 4.3.2 Fresenius Kabi AG Business Overview
- 4.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Fresenius Kabi AG Intravenous Solutions (Colloids) Product Portfolio
- 4.3.5 Fresenius Kabi AG Recent Developments
- 4.4 Baxter
- 4.4.1 Baxter Company Information
- 4.4.2 Baxter Business Overview
- 4.4.3 Baxter Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Baxter Intravenous Solutions (Colloids) Product Portfolio
- 4.4.5 Baxter Recent Developments
- 4.5 Amanta Healthcare
- 4.5.1 Amanta Healthcare Company Information
- 4.5.2 Amanta Healthcare Business Overview
- 4.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Amanta Healthcare Intravenous Solutions (Colloids) Product Portfolio
- 4.5.5 Amanta Healthcare Recent Developments
- 4.6 Terumo Medical Corporation
- 4.6.1 Terumo Medical Corporation Company Information
- 4.6.2 Terumo Medical Corporation Business Overview
- 4.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Terumo Medical Corporation Intravenous Solutions (Colloids) Product Portfolio
- 4.6.5 Terumo Medical Corporation Recent Developments
- 4.7 Grifols S.A.
- 4.7.1 Grifols S.A. Company Information
- 4.7.2 Grifols S.A. Business Overview
- 4.7.3 Grifols S.A. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Grifols S.A. Intravenous Solutions (Colloids) Product Portfolio
- 4.7.5 Grifols S.A. Recent Developments
5 Global Intravenous Solutions (Colloids) Market Scenario by Region
- 5.1 Global Intravenous Solutions (Colloids) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Intravenous Solutions (Colloids) Sales by Region: 2021-2032
- 5.2.1 Global Intravenous Solutions (Colloids) Sales by Region: 2021-2026
- 5.2.2 Global Intravenous Solutions (Colloids) Sales by Region: 2027-2032
- 5.3 Global Intravenous Solutions (Colloids) Revenue by Region: 2021-2032
- 5.3.1 Global Intravenous Solutions (Colloids) Revenue by Region: 2021-2026
- 5.3.2 Global Intravenous Solutions (Colloids) Revenue by Region: 2027-2032
- 5.4 North America Intravenous Solutions (Colloids) Market Facts & Figures by Country
- 5.4.1 North America Intravenous Solutions (Colloids) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Intravenous Solutions (Colloids) Sales by Country (2021-2032)
- 5.4.3 North America Intravenous Solutions (Colloids) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Intravenous Solutions (Colloids) Market Facts & Figures by Country
- 5.5.1 Europe Intravenous Solutions (Colloids) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Intravenous Solutions (Colloids) Sales by Country (2021-2032)
- 5.5.3 Europe Intravenous Solutions (Colloids) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Intravenous Solutions (Colloids) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Intravenous Solutions (Colloids) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Intravenous Solutions (Colloids) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Intravenous Solutions (Colloids) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Intravenous Solutions (Colloids) Market Facts & Figures by Country
- 5.7.1 South America Intravenous Solutions (Colloids) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Intravenous Solutions (Colloids) Sales by Country (2021-2032)
- 5.7.3 South America Intravenous Solutions (Colloids) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Intravenous Solutions (Colloids) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Intravenous Solutions (Colloids) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Intravenous Solutions (Colloids) Sales by Type (2021-2032)
- 6.1.1 Global Intravenous Solutions (Colloids) Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Intravenous Solutions (Colloids) Sales Market Share by Type (2021-2032)
- 6.2 Global Intravenous Solutions (Colloids) Revenue by Type (2021-2032)
- 6.2.1 Global Intravenous Solutions (Colloids) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2021-2032)
- 6.3 Global Intravenous Solutions (Colloids) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Intravenous Solutions (Colloids) Sales by Application (2021-2032)
- 7.1.1 Global Intravenous Solutions (Colloids) Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Intravenous Solutions (Colloids) Sales Market Share by Application (2021-2032)
- 7.2 Global Intravenous Solutions (Colloids) Revenue by Application (2021-2032)
- 7.2.1 Global Intravenous Solutions (Colloids) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2021-2032)
- 7.3 Global Intravenous Solutions (Colloids) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Intravenous Solutions (Colloids) Value Chain Analysis
- 8.1.1 Intravenous Solutions (Colloids) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Intravenous Solutions (Colloids) Production Mode & Process
- 8.2 Intravenous Solutions (Colloids) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Intravenous Solutions (Colloids) Distributors
- 8.2.3 Intravenous Solutions (Colloids) Customers
9 Global Intravenous Solutions (Colloids) Analyzing Market Dynamics
- 9.1 Intravenous Solutions (Colloids) Industry Trends
- 9.2 Intravenous Solutions (Colloids) Industry Drivers
- 9.3 Intravenous Solutions (Colloids) Industry Opportunities and Challenges
- 9.4 Intravenous Solutions (Colloids) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst